297 related articles for article (PubMed ID: 18624680)
1. Intestinal efflux transporters and drug absorption.
Murakami T; Takano M
Expert Opin Drug Metab Toxicol; 2008 Jul; 4(7):923-39. PubMed ID: 18624680
[TBL] [Abstract][Full Text] [Related]
2. Expression and function of efflux drug transporters in the intestine.
Takano M; Yumoto R; Murakami T
Pharmacol Ther; 2006 Jan; 109(1-2):137-61. PubMed ID: 16209890
[TBL] [Abstract][Full Text] [Related]
3. Intestinal transporters: enhanced absorption through P-glycoprotein-related drug interactions.
Zakeri-Milani P; Valizadeh H
Expert Opin Drug Metab Toxicol; 2014 Jun; 10(6):859-71. PubMed ID: 24708201
[TBL] [Abstract][Full Text] [Related]
4. Correlation of gene expression of ten drug efflux proteins of the ATP-binding cassette transporter family in normal human jejunum and in human intestinal epithelial Caco-2 cell monolayers.
Taipalensuu J; Törnblom H; Lindberg G; Einarsson C; Sjöqvist F; Melhus H; Garberg P; Sjöström B; Lundgren B; Artursson P
J Pharmacol Exp Ther; 2001 Oct; 299(1):164-70. PubMed ID: 11561076
[TBL] [Abstract][Full Text] [Related]
5. The bioavailability and distribution of trans-resveratrol are constrained by ABC transporters.
Planas JM; Alfaras I; Colom H; Juan ME
Arch Biochem Biophys; 2012 Nov; 527(2):67-73. PubMed ID: 22750234
[TBL] [Abstract][Full Text] [Related]
6. Interaction of angiotensin receptor type 1 blockers with ATP-binding cassette transporters.
Weiss J; Sauer A; Divac N; Herzog M; Schwedhelm E; Böger RH; Haefeli WE; Benndorf RA
Biopharm Drug Dispos; 2010 Mar; 31(2-3):150-61. PubMed ID: 20222053
[TBL] [Abstract][Full Text] [Related]
7. Resolution of P-glycoprotein and non-P-glycoprotein effects on drug permeability using intestinal tissues from mdr1a (-/-) mice.
Stephens RH; O'Neill CA; Bennett J; Humphrey M; Henry B; Rowland M; Warhurst G
Br J Pharmacol; 2002 Apr; 135(8):2038-46. PubMed ID: 11959808
[TBL] [Abstract][Full Text] [Related]
8. A new mechanism for increasing the oral bioavailability of scutellarin with Cremophor EL: Activation of MRP3 with concurrent inhibition of MRP2 and BCRP.
Xiao L; Yi T; Chen M; Lam CW; Zhou H
Eur J Pharm Sci; 2016 Oct; 93():456-67. PubMed ID: 27586020
[TBL] [Abstract][Full Text] [Related]
9. Restricting CNS penetration of drugs to minimise adverse events: role of drug transporters.
Bagal S; Bungay P
Drug Discov Today Technol; 2014 Jun; 12():e79-85. PubMed ID: 25027378
[TBL] [Abstract][Full Text] [Related]
10. Interplay of metabolism and transport in determining oral drug absorption and gut wall metabolism: a simulation assessment using the "Advanced Dissolution, Absorption, Metabolism (ADAM)" model.
Darwich AS; Neuhoff S; Jamei M; Rostami-Hodjegan A
Curr Drug Metab; 2010 Nov; 11(9):716-29. PubMed ID: 21189140
[TBL] [Abstract][Full Text] [Related]
11. Multiple ABC Transporters Efflux Baicalin.
Kalapos-Kovács B; Magda B; Jani M; Fekete Z; Szabó PT; Antal I; Krajcsi P; Klebovich I
Phytother Res; 2015 Dec; 29(12):1987-90. PubMed ID: 26400418
[TBL] [Abstract][Full Text] [Related]
12. [Role of ABC efflux transporters in the oral bioavailability and drug-induced intestinal toxicity].
Yokooji T
Yakugaku Zasshi; 2013; 133(7):815-22. PubMed ID: 23811769
[TBL] [Abstract][Full Text] [Related]
13. Expression of ATP-binding cassette membrane transporters in rodent and human sertoli cells: relevance to the permeability of antiretroviral therapy at the blood-testis barrier.
Robillard KR; Hoque T; Bendayan R
J Pharmacol Exp Ther; 2012 Jan; 340(1):96-108. PubMed ID: 21990609
[TBL] [Abstract][Full Text] [Related]
14. Functional ATP-binding cassette drug efflux transporters in isolated human and rat hepatocytes significantly affect assessment of drug disposition.
Lundquist P; Englund G; Skogastierna C; Lööf J; Johansson J; Hoogstraate J; Afzelius L; Andersson TB
Drug Metab Dispos; 2014 Mar; 42(3):448-58. PubMed ID: 24396144
[TBL] [Abstract][Full Text] [Related]
15. Active secretion and enterocytic drug metabolism barriers to drug absorption.
Wacher VJ; Salphati L; Benet LZ
Adv Drug Deliv Rev; 2001 Mar; 46(1-3):89-102. PubMed ID: 11259835
[TBL] [Abstract][Full Text] [Related]
16. Pharmacogenetics of drug transporters.
Franke RM; Gardner ER; Sparreboom A
Curr Pharm Des; 2010; 16(2):220-30. PubMed ID: 19835554
[TBL] [Abstract][Full Text] [Related]
17. Small intestinal efflux mediated by MRP2 and BCRP shifts sulfasalazine intestinal permeability from high to low, enabling its colonic targeting.
Dahan A; Amidon GL
Am J Physiol Gastrointest Liver Physiol; 2009 Aug; 297(2):G371-7. PubMed ID: 19541926
[TBL] [Abstract][Full Text] [Related]
18. Modulation of expression/function of intestinal P-glycoprotein under disease states.
Murakami T; Bodor E; Bodor N
Expert Opin Drug Metab Toxicol; 2020 Jan; 16(1):59-78. PubMed ID: 31821048
[No Abstract] [Full Text] [Related]
19. Clinical relevance of drug efflux pumps in the gut.
Misaka S; Müller F; Fromm MF
Curr Opin Pharmacol; 2013 Dec; 13(6):847-52. PubMed ID: 24028838
[TBL] [Abstract][Full Text] [Related]
20. Novel understanding of ABC transporters ABCB1/MDR/P-glycoprotein, ABCC2/MRP2, and ABCG2/BCRP in colorectal pathophysiology.
Andersen V; Svenningsen K; Knudsen LA; Hansen AK; Holmskov U; Stensballe A; Vogel U
World J Gastroenterol; 2015 Nov; 21(41):11862-76. PubMed ID: 26557010
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
